CVS Health’s iShares 10+ Year Investment Grade Corporate Bond ETF IGLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.5M Buy
230,000
+55,000
+31% +$2.64M 2.45% 11
2026
Q2
$8.76M Buy
175,000
+75,000
+75% +$3.74M 3.89% 9
2026
Q1
$4.96M Buy
+100,000
New +$5.05M 2.34% 13

Other funds holding IGLB

CVS Health's IGLB Position: Q3 2026 in Review

CVS Health increased its iShares 10+ Year Investment Grade Corporate Bond ETF (IGLB) stake by 31% in Q3 2026, buying an estimated $2.64M and bringing the position to 230,000 shares worth $10.5M. The position accounts for 2.45% of the portfolio, ranked #11.

CVS Health first reported a position in IGLB in Q1 2026 and has held it in 3 quarters since. 207 funds tracked by Wall St. Rank hold IGLB as of Q3 2026.

  • CVS Health held 230,000 shares of iShares 10+ Year Investment Grade Corporate Bond ETF worth $10.5M as of Q3 2026.
  • CVS Health bought 55,000 iShares 10+ Year Investment Grade Corporate Bond ETF shares in Q3 2026, an estimated $2.64M.
  • iShares 10+ Year Investment Grade Corporate Bond ETF made up 2.45% of CVS Health's portfolio in Q3 2026, its #11 holding.
  • CVS Health first reported a position in iShares 10+ Year Investment Grade Corporate Bond ETF in Q1 2026 and has held it in 3 quarters since.
  • 207 funds tracked by Wall St. Rank held iShares 10+ Year Investment Grade Corporate Bond ETF as of Q3 2026.

Based on CVS Health's 13F filing for Q3 2026, filed 5 Nov 2026.